Sigma receptors: From discovery to highlights of their implications in the cardiovascular system

Fundamental and Clinical Pharmacology

Volumn 16, Issue 1, 2002, Pages 1-8

  Monassier, Laurent ^a   Bousquet, Pascal ^a  

^a UNIVERSITÉ DE STRASBOURG   (France)

Author keywords

Cardiac contractility; G proteins; K+ channels; Rhythm; Sigma receptors; Vasomotricity

Indexed keywords

1,3 BIS(2 METHYLPHENYL)GUANIDINE; 3 HYDROXYPHENYL 1 PROPYLPIPERIDINE; AMIODARONE; ANTIARRHYTHMIC AGENT; BD 1063; CHLORPROMAZINE; CLOFILIUM; DEXTROMETHORPHAN; DOPAMINE; DOPAMINE 2 RECEPTOR BLOCKING AGENT; ENDORPHIN DERIVATIVE; ENKEPHALIN DERIVATIVE; HALOPERIDOL; IBOGAINE; IFENPRODIL; KETAZOCINE; MORPHINE; N [2 (2,3 DICHLOROPHENYL)ETHYL] 2 DIMETHYLAMINO N METHYLETHYLAMINE; N ALLYLNORMETAZOCINE; NALOXONE; NALTREXONE; NEOMYCIN; NORADRENALIN; PENTAZOCINE; PHENCYCLIDINE; PRECLAMOL; PSYCHOTROPIC AGENT; RECEPTOR SUBTYPE; REMOXIPRIDE; RIMCAZOLE; SIGMA 1 OPIATE RECEPTOR; SIGMA OPIATE RECEPTOR; UNCLASSIFIED DRUG;

BINDING SITE; CARDIOVASCULAR FUNCTION; CARDIOVASCULAR SYSTEM; CORONARY ARTERY; DRUG EFFECT; HEART ARRHYTHMIA; HEART MUSCLE CONTRACTILITY; HEART RHYTHM; HUMAN; NONHUMAN; PRIORITY JOURNAL; PROTEIN FAMILY; REGULATORY MECHANISM; REVIEW; TISSUE DISTRIBUTION; VASOMOTOR REFLEX;

ANIMALS; ANTI-ARRHYTHMIA AGENTS; CARDIOVASCULAR SYSTEM; HUMANS; LIGANDS; MYOCARDIAL CONTRACTION; RECEPTORS, SIGMA;

EID: 0036218761     PISSN: 07673981     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1472-8206.2002.00063.x     Document Type: Review

References (50)

1. The effects of morphine and nalorphine-like drugs in the nondependent and morphine-dependent chronic spinal dog
2. Enigmatic receptors
3. The opioid receptor binding of dezocine, morphine, fentanyl, butorphanol and nalbuphine
4. Discriminative stimulus properties of opioids that interact with mu, kappa and PCP/sigma receptors
5. Receptor site topographies for phencyclidine-like and σ drugs: Predictions from quantitative conformational, electrostatic potential, and radioreceptor analysis
6. Neuroprotective and anti-amnesic potentials of sigma (s) receptor ligands
7. Novel antipsychotics share high affinity for σ receptors
8. Design, synthesis, structure-activity relationships, and biological characterization of novel arylalkoxyphenylalkylamine σ ligands as potential antipsychotic drugs
9. Sigma receptors: Recent advances and new clinical potentials
10. Sigma-receptors in endocrine organs: Identification, characterization, and autoradiographic locali in rat pituitary, adrenal testis, and ovary
11. Autoradiographic localization of sigma opioid receptors in the gastrointestinal tract of the guinea pig
12. Immunocytochemical localization of the sigma (1) receptor in the adult rat central system
13. Differential solubilization of rat liver sigma 1 and sigma 2 receptors: Retention of sigma 2 sites in particulate fractions
14. Sigma receptor ligands modulate contractility, Ca++ influx and beating rate in cultured cardiac myocytes
15. A proposal for the classification of sigma binding sites
16. 3H]ifenprodil binding to σ receptors in rat brain
17. Efficacy and safety of an opiate sigma-receptor antagonist (SL 82-0715) in schizophrenic patients with negative symptoms: An open dose-range study
18. Effect of ibogaine on the various sites of the NMDA receptor complex and sigma binding sites in rat brain
19. Progress in sigma receptor research
20. Rat liver and kidney contain high densities of sigma 1 and sigma 2 receptors: Characterization by ligand binding and photoaffinity labeling
21. 1-binding site
22. The mysteries of sigma receptors: New family members reveal a role in cholesterol synthesis
23. Cloning and functional expression of the human type 1 sigma receptor (hSigmaR1)
24. Cloning and structural analysis of the cDNA and the gene encoding the murine type 1 sigma receptor
25. Cloning and functional characterization of a sigma receptor from rat brain
26. Identification of a 27 kDa high affinity phenylalkylamine-binding polypeptide as the sigma 1 binding site by photoaffinity labeling and ligand directed antibodies
27. Dermosterolosis: A new inborn error of cholesterol biosynthesis
28. Exon-intron structure, analysis of promoter region, and chromosomal localization of the human type 1 sigma receptor gene
29. Association between polymorphisms in the type 1 sigma receptor gene and schizophrenia
30. Sigma-binding site ligands inhibit K+ currents in rat locus coeruleus neurons in vitro
31. Blockade by sigma site ligands of high voltage-activated Ca2+ channels in rat and mouse cultured hippocampal pyramidal neurons
32. Sigma ligands stimulate GTPase activity in mouse prefrontal membranes: Evidence for the existence of metabotropic sigma receptors
33. 1 receptor modulates phospholipase C and protein kinase C activities in the brainstem
34. Modulation of cellular calcium by sigma-2 receptors: Release from intracellular stores in human SK-N-SH neuroblastoma cells
35. Regulation of [3H]norepinephrine release from guinea pig hippocampus by sigma 2 receptors
36. Sigma receptor ligands and imidazoline secretagogues mediate their insulin secretory effects by activating distinct receptor systems in isolated islets
37. The effect of sigma ligands on the release of glutamate from rat striatal slices
38. Interaction of 1,3-di (2-[(5-3H]tolyl) guanidine with sigma 2 binding sites in rat heart membrane preparations
39. Inotropic action of sigma receptor ligands in isolated cardiac myocytes from adult rats
40. Apparent desensitization of a sigma receptor sub-population in neonatal cardiac myocytes by pre-treatment with sigma receptor ligands
41. Highly selective σ receptor ligands elevate inositol 1,4,5-trisphosphate production in rat cardiac myocytes
42. Ligands for opioid and sigma-receptors improve cardiac electrical stability in rat models of post-infarction cardiosclerosis and stress
43. The anti-arrhythmia and pro-arrhythmia properties of sigma-receptor ligands
44. + channel of class III antiarrhythmic drugs?
45. Multiple sites of action of (+)-3-(3-hydroxyphenyl) -N-(1-propyl) piperidine ((+)-3PPP) in blood vessels
46. Multiple vascular effects of sigma and PCP ligands: Inhibition of amine uptake and contractile responses
47. Interaction of sigma and phencyclidine receptor ligands with the norepinephrine uptake carrier in both rat brain and rat tail artery
48. Sigma receptor ligands inhibit rat tail artery contractile responses by multiple mechanisms
49. Effect of phencyclidine on contraction of porcine coronary vessel strips
50. Cocaïne increases the endothelial release of immunoreactive endothelin and its concentrations in human plasma and urine. Reversal by coincubation with σ-receptor antagonists